38.66
Astrana Health Inc stock is traded at $38.66, with a volume of 25,516.
It is down -0.27% in the last 24 hours and down -15.02% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$38.74
Open:
$38.9
24h Volume:
25,516
Relative Volume:
0.04
Market Cap:
$1.92B
Revenue:
$3.53B
Net Income/Loss:
$30.99M
P/E Ratio:
63.02
EPS:
0.6134
Net Cash Flow:
$154.99M
1W Performance:
-5.33%
1M Performance:
-15.02%
6M Performance:
+94.53%
1Y Performance:
+28.91%
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ASTH
Astrana Health Inc
|
38.66 | 1.95B | 3.53B | 30.99M | 154.99M | 0.6134 |
|
HCA
Hca Healthcare Inc
|
423.55 | 88.13B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
278.23 | 21.62B | 21.46B | 2.65B | 3.35B | 19.23 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.50 | 12.69B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
122.17 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
174.35 | 11.31B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Astrana Health (ASTH) Shares Just Moved, So What Is Going On? - Sahm
Astrana Health Director David Schmidt Executes Option Exercise and Sells Shares via Issuer Repurchase - Kalkine Media
Astrana Health (NASDAQ: ASTH) director sells 20K shares back to company - Stock Titan
ASTH | Astrana Health Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Surges 7.99% to $40.81 — Key Levels to WatchHigh Beta Stocks - Vinanet
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call - Yahoo Finance
Astrana Health Inc (ASTH) Shares Surge 8.2% -- What GF Score of 85 Tells Investors - GuruFocus
Astrana Health (NASDAQ:ASTH) Rally Puts Growth In Focus - Kalkine Media
Astrana Health Jumps 7.1% After Truist Securities Maintains Buy - AlphaStreet
Astrana Health (ASTH) Surges 7.57% as Healthcare Services Stock Breaks HigherLow Risk Entry Stocks - Vinanet
Astrana Health (NASDAQ:ASTH) Shares Up 7.9%Still a Buy? - MarketBeat
Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net IncomeHas The Bull Case Changed? - simplywall.st
ASTH Q2 2026 Earnings: 16.7% EPS Beat Drives OptimismSaaS Earnings Trends - Vinanet
Astrana Health: 81% Full-Risk And Profitable (NASDAQ:ASTH) - Seeking Alpha
Is Astrana Health Inc (ASTH) a Bargain After 8.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (NASDAQ:ASTH) Stock Price Down 5.7%What's Next? - MarketBeat
ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47 - Bitget
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Truist Securities Adjusts Price Target on Astrana Health to $55 From $47, Keeps Buy Rating - marketscreener.com
Astrana Health Inc. (ASTH) Stock Analysis: Exploring A 34.77% Potential Upside - DirectorsTalk Interviews
Astrana Health Submits Q2 2026 SEC Form 10-Q Detailing Financials and Share Information - Kalkine Media
Astrana Health, Inc. Q2 2026: Revenue $972.5M, EPS $0.4— 10-Q Summary - TradingView
Astrana Health (ASTH) grows Q2 2026 revenue to $972.5M with stronger profit - stocktitan.net
Results: Astrana Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - 富途牛牛
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Astrana Health Management, Inc., for Alleged Violations of Meal & Rest Period Requirements - PR Newswire
Sei Investments Co. Raises Stake in Astrana Health, Inc. $ASTH - MarketBeat
Barclays Sticks to Their Buy Rating for Astrana Health (ASTH) - The Globe and Mail
Astrana Health (NASDAQ:ASTH) Raised to Buy at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Stock Rises On Cash Flow Strength And Deleveraging - simplywall.st
Astrana Health Inc. Stock 12‑Month Price Target Raised to $50.5, Implies 48% Upside - TradingView
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53 - Moomoo
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress - Yahoo Finance
Enterprise value to revenue forward of Astrana Health Inc. – FWB:3AM - TradingView
Astrana Health (ASTH) Surges 5.22% as Momentum Builds Toward Key ResistanceComposite Profile - Vinanet
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook - The Globe and Mail
Astrana Health beats EPS estimates, raises EBITDA guidance By Investing.com - Investing.com Nigeria
Astrana Health, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Astrana Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ASTH) 2026-08-06 - Seeking Alpha
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts - Investing.com
Astrana Health Q2 Earnings Call Highlights - MarketBeat
ASTH Looks 59.4% Undervalued on GF Value™ - GuruFocus
Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates - Yahoo Finance
ASTRANA HEALTH ($ASTH) Releases Q2 2026 Earnings - Quiver Quantitative
Earnings Flash (ASTH) Astrana Health, Inc. Posts Q2 Adjusted EPS $0.80 per Share, vs. FactSet Est of $0.79 - marketscreener.com
Earnings Flash (ASTH) Astrana Health, Inc. Reports Q2 Revenue $972.5M, vs. FactSet Est of $985.6M - marketscreener.com
(ASTH) Astrana Health, Inc. Expects Q3 Revenue Range $1.00B$1.03B - marketscreener.com
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1% - Barchart.com
Astrana Health, Inc. Reports Second Quarter 2026 Results - PR Newswire
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sim Brandon | CEO and President |
Feb 02 '26 |
Option Exercise |
23.24 |
21,334 |
495,802 |
1,045,329 |
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):